BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 26194317)

  • 21. The Alzheimer's Disease Neuroimaging Initiative informatics core: A decade in review.
    Toga AW; Crawford KL
    Alzheimers Dement; 2015 Jul; 11(7):832-9. PubMed ID: 26194316
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mapping longitudinal scientific progress, collaboration and impact of the Alzheimer's disease neuroimaging initiative.
    Yao X; Yan J; Ginda M; Börner K; Saykin AJ; Shen L;
    PLoS One; 2017; 12(11):e0186095. PubMed ID: 29095836
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Common Alzheimer's Disease Research Ontology: National Institute on Aging and Alzheimer's Association collaborative project.
    Refolo LM; Snyder H; Liggins C; Ryan L; Silverberg N; Petanceska S; Carrillo MC
    Alzheimers Dement; 2012 Jul; 8(4):372-5. PubMed ID: 22748941
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Worldwide Alzheimer's Disease Neuroimaging Initiative: ADNI-3 updates and global perspectives.
    Weber CJ; Carrillo MC; Jagust W; Jack CR; Shaw LM; Trojanowski JQ; Saykin AJ; Beckett LA; Sur C; Rao NP; Mendez PC; Black SE; Li K; Iwatsubo T; Chang CC; Sosa AL; Rowe CC; Perrin RJ; Morris JC; Healan AMB; Hall SE; Weiner MW
    Alzheimers Dement (N Y); 2021; 7(1):e12226. PubMed ID: 35005206
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Creation of the Argentina-Alzheimer's Disease Neuroimaging Initiative.
    Russo MJ; Gustafson D; Vázquez S; Surace E; Guinjoan S; Allegri RF; Sevlever G;
    Alzheimers Dement; 2014 Feb; 10(1 Suppl):S84-7. PubMed ID: 24864324
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advanced psychometric analysis and the Alzheimer's Disease Neuroimaging Initiative: reports from the 2011 Friday Harbor conference.
    Mungas D; Crane PK; Gibbons LE; Manly JJ; Glymour MM; Jones RN
    Brain Imaging Behav; 2012 Dec; 6(4):485-8. PubMed ID: 23232798
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validation of Alzheimer's disease CSF and plasma biological markers: the multicentre reliability study of the pilot European Alzheimer's Disease Neuroimaging Initiative (E-ADNI).
    Buerger K; Frisoni G; Uspenskaya O; Ewers M; Zetterberg H; Geroldi C; Binetti G; Johannsen P; Rossini PM; Wahlund LO; Vellas B; Blennow K; Hampel H
    Exp Gerontol; 2009 Sep; 44(9):579-85. PubMed ID: 19539742
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detecting early preclinical Alzheimer's disease via cognition, neuropsychiatry, and neuroimaging: qualitative review and recommendations for testing.
    Belleville S; Fouquet C; Duchesne S; Collins DL; Hudon C
    J Alzheimers Dis; 2014; 42 Suppl 4():S375-82. PubMed ID: 25190629
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expanding efforts to address Alzheimer's disease: the Healthy Brain Initiative.
    Anderson LA; Egge R
    Alzheimers Dement; 2014 Oct; 10(5 Suppl):S453-6. PubMed ID: 25088658
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Workgroup on NAPA's scientific agenda for a national initiative on Alzheimer's disease.
    Alzheimer's Association Expert Advisory Workgroup on NAPA
    Alzheimers Dement; 2012 Jul; 8(4):357-71. PubMed ID: 22748940
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Alzheimer's Disease Cooperative Study (ADCS)].
    Mori H; Ikeuchi T
    Brain Nerve; 2014 Jun; 66(6):691-8. PubMed ID: 24899351
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Private sector contributions to pharmaceutical science: thirty-five summary case histories.
    Zycher B; DiMasi JA; Milne CP
    Am J Ther; 2010; 17(1):101-20. PubMed ID: 20027102
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnosis and management of Alzheimer's disease: past, present and future ethical issues.
    Gauthier S; Leuzy A; Racine E; Rosa-Neto P
    Prog Neurobiol; 2013 Nov; 110():102-13. PubMed ID: 23578568
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Screening and enrollment of underrepresented ethnocultural and educational populations in the Alzheimer's Disease Neuroimaging Initiative (ADNI).
    Ashford MT; Raman R; Miller G; Donohue MC; Okonkwo OC; Mindt MR; Nosheny RL; Coker GA; Petersen RC; Aisen PS; Weiner MW;
    Alzheimers Dement; 2022 Dec; 18(12):2603-2613. PubMed ID: 35213778
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Biomarkers for Alzheimer's disease: after Alzheimer's disease neuroimaging initiative studies].
    Shoji M
    Brain Nerve; 2012 May; 64(5):497-504. PubMed ID: 22570063
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Food industry: friend or foe?
    Yach D
    Obes Rev; 2014 Jan; 15(1):2-5. PubMed ID: 24180599
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Current topics about mild cognitive impairment (MCI)].
    Yamamoto Y
    Seishin Shinkeigaku Zasshi; 2011; 113(6):584-92. PubMed ID: 21815470
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Addressing population aging and Alzheimer's disease through the Australian imaging biomarkers and lifestyle study: collaboration with the Alzheimer's Disease Neuroimaging Initiative.
    Ellis KA; Rowe CC; Villemagne VL; Martins RN; Masters CL; Salvado O; Szoeke C; Ames D;
    Alzheimers Dement; 2010 May; 6(3):291-6. PubMed ID: 20451879
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Partnership between academia and industry for drug discovery in Alzheimer's disease.
    Ivinson AJ; Lane R; May PC; Hosford DA; Carrillo MC; Siemers ER
    Alzheimers Dement; 2008 Mar; 4(2):80-8. PubMed ID: 18631952
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.